Publication

Toll-Like Receptors 2 and 3 Agonists Differentially Affect Oligodendrocyte Survival, Differentiation, and Myelin Membrane Formation

Bsibsi, M., Nomden, A., van Noort, J. M. & Baron, W., Feb-2012, In : Journal of Neuroscience Research. 90, 2, p. 388-398 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

  • Malika Bsibsi
  • Anita Nomden
  • Johannes M. van Noort
  • Wia Baron

Toll-like receptors (TLRs) play a key role in controlling innate immune responses to a wide variety of pathogen-associated molecules as well as endogenous signals. In addition, TLR expression within nonimmune cells has been recognized as as modulator of cell behavior. In this study we have addressed the question of whether functional TLRs are expressed on oligodendrocytes, the myelinating cells of the central nervous system. Primary cultures of rat oligodendrocytes at different maturation stages were found to express TLR2 and, to lesser extent, TLR3. Immunocytochemical analysis revealed that both TLRs were localized at the cell body and primary processes and were excluded from myelin-like membranes. Interestingly, innate immune receptor ligands were able to modulate oligodendrocyte survival, differentiation, and myelin-like membrane formation, indicating that TLRs on oligodendrocytes are functional. In highly purified oligodendrocytes cultures, the TLR2 agonist zymosan promoted survival, differentiation, and myelin-like membrane formation, whereas poly-I:C, a TLR3 ligand, was a potent inducer of apoptosis. Together, these data indicate that, in addition to other neural cell types, also oligodendrocytes express functional TLRs, which play a role in regulating various aspects of oligodendrocyte behavior. (C) 2011 Wiley Periodicals, Inc.

Original languageEnglish
Pages (from-to)388-398
Number of pages11
JournalJournal of Neuroscience Research
Volume90
Issue number2
Publication statusPublished - Feb-2012

    Keywords

  • myelin, oligodendrocyte, toll-like receptor, CENTRAL-NERVOUS-SYSTEM, INNATE IMMUNITY, NEGATIVE REGULATOR, STRANDED-RNA, RIG-I, LIPOPOLYSACCHARIDE, INJURY, INFLAMMATION, RECOGNITION, ACTIVATION

ID: 5481575